Dimensional Fund Advisors
TEVA icon

Dimensional Fund Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Dimensional Fund Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Buy
3,117,628
+253,034
+9% +$8.43M 0.02% 1132
2026
Q1 		$86.2M Buy
2,864,594
+73,410
+3% +$2.36M 0.02% 1165
2025
Q4 		$87.1M Sell
2,791,184
-1,548
-0.1% -$38.1K 0.02% 1172
2025
Q3 		$56.4M Buy
2,792,732
+17,305
+0.6% +$304K 0.01% 1452
2025
Q2 		$46.5M Buy
2,775,427
+26,559
+1% +$429K 0.01% 1541
2025
Q1 		$42.2M Buy
2,748,868
+137,125
+5% +$2.45M 0.01% 1560
2024
Q4 		$57.6M Buy
2,611,743
+313,817
+14% +$5.71M 0.01% 1436
2024
Q3 		$41.4M Buy
2,297,926
+831,222
+57% +$14.5M 0.01% 1617
2024
Q2 		$23.8M Buy
1,466,704
+274,891
+23% +$4.23M 0.01% 1877
2024
Q1 		$16.8M Buy
1,191,813
+53,466
+5% +$674K ﹤0.01% 2074
2023
Q4 		$11.9M Sell
1,138,347
-57,955
-5% -$541K ﹤0.01% 2246
2023
Q3 		$12.2M Sell
1,196,302
-587,494
-33% -$5.47M ﹤0.01% 2155
2023
Q2 		$13.4M Sell
1,783,796
-1,691,067
-49% -$13.7M ﹤0.01% 2127
2023
Q1 		$30.8M Buy
+3,474,863
New +$34.4M 0.01% 1676
2022
Q3 		$38.2M Sell
4,730,246
-881,152
-16% -$7.79M 0.01% 1432
2022
Q2 		$42.2M Sell
5,611,398
-394,954
-7% -$3.44M 0.02% 1415
2022
Q1 		$56.4M Buy
6,006,352
+732,558
+14% +$6.11M 0.02% 1317
2021
Q4 		$42.2M Buy
5,273,794
+1,743,292
+49% +$15.7M 0.01% 1529
2021
Q3 		$34.4M Buy
3,530,502
+272,981
+8% +$2.56M 0.01% 1692
2021
Q2 		$32.2M Buy
3,257,521
+239,782
+8% +$2.54M 0.01% 1779
2021
Q1 		$34.8M Buy
3,017,739
+691,716
+30% +$7.93M 0.01% 1711
2020
Q4 		$22.4M Buy
2,326,023
+40,604
+2% +$389K 0.01% 1918
2020
Q3 		$20.6M Sell
2,285,419
-239,358
-9% -$2.53M 0.01% 1833
2020
Q2 		$31.1M Sell
2,524,777
-348,513
-12% -$3.94M 0.01% 1576
2020
Q1 		$25.8M Buy
2,873,290
+1,187,765
+70% +$12.2M 0.01% 1574
2019
Q4 		$16.5M Buy
1,685,525
+896,273
+114% +$8M 0.01% 2143
2019
Q3 		$5.43M Buy
789,252
+238,371
+43% +$1.83M ﹤0.01% 2569
2019
Q2 		$5.08M Buy
550,881
+3,009
+0.5% +$36.3K ﹤0.01% 2629
2019
Q1 		$8.59M Sell
547,872
-56,171
-9% -$991K ﹤0.01% 2459
2018
Q4 		$9.31M Sell
604,043
-461,618
-43% -$9.46M ﹤0.01% 2371
2018
Q3 		$23M Sell
1,065,661
-19,568
-2% -$454K 0.01% 2041
2018
Q2 		$26.4M Sell
1,085,229
-100,312
-8% -$2.05M 0.01% 1959
2018
Q1 		$20.3M Buy
1,185,541
+168,658
+17% +$3.29M 0.01% 2048
2017
Q4 		$19.3M Sell
1,016,883
-18,952
-2% -$285K 0.01% 2077
2017
Q3 		$18.2M Buy
1,035,835
+46,229
+5% +$1.04M 0.01% 2105
2017
Q2 		$32.9M Sell
989,606
-130,714
-12% -$4.05M 0.02% 1663
2017
Q1 		$36M Sell
1,120,320
-30,578
-3% -$1.04M 0.02% 1529
2016
Q4 		$41.7M Sell
1,150,898
-6,673
-0.6% -$266K 0.02% 1335
2016
Q3 		$53.3M Buy
1,157,571
+25,822
+2% +$1.35M 0.03% 964
2016
Q2 		$56.8M Sell
1,131,749
-73,530
-6% -$3.91M 0.03% 832
2016
Q1 		$64.5M Buy
1,205,279
+26,610
+2% +$1.56M 0.04% 665
2015
Q4 		$77.4M Sell
1,178,669
-89,363
-7% -$5.52M 0.05% 498
2015
Q3 		$71.6M Buy
1,268,032
+157,983
+14% +$10.2M 0.05% 519
2015
Q2 		$65.6M Buy
1,110,049
+33,217
+3% +$2.05M 0.04% 623
2015
Q1 		$67.1M Buy
1,076,832
+43,319
+4% +$2.52M 0.04% 585
2014
Q4 		$59.4M Sell
1,033,513
-2,107
-0.2% -$117K 0.04% 620
2014
Q3 		$55.7M Buy
1,035,620
+184,849
+22% +$9.79M 0.04% 603
2014
Q2 		$44.6M Buy
850,771
+232,979
+38% +$11.9M 0.03% 812
2014
Q1 		$32.6M Sell
617,792
-6,429
-1% -$297K 0.02% 1029
2013
Q4 		$25M Buy
624,221
+67,659
+12% +$2.66M 0.02% 1291
2013
Q3 		$21M Buy
556,562
+119,164
+27% +$4.65M 0.02% 1363
2013
Q2 		$17.1M Buy
+437,398
New +$17M 0.02% 1467

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Dimensional Fund Advisors's TEVA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Teva Pharmaceuticals (TEVA) stake by 8.8% in Q2 2026, buying an estimated $8.43M and bringing the position to 3,117,628 shares worth $106M. The position accounts for 0.02% of the portfolio, ranked #1132.

Dimensional Fund Advisors first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Dimensional Fund Advisors held 3,117,628 shares of Teva Pharmaceuticals worth $106M as of Q2 2026.
  • Dimensional Fund Advisors bought 253,034 Teva Pharmaceuticals shares in Q2 2026, an estimated $8.43M.
  • Teva Pharmaceuticals made up 0.02% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1132 holding.
  • Dimensional Fund Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.